MedTrace Logo

Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation

NCT00196183 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2008-03-18

No results posted yet for this study

Summary

The purpose of this study is to compare two strategies of catheter-based treatment of paroxysmal atrial fibrillation: Pulmonary vein isolation either alone or combined with electrogram-guided substrate-ablation.

Conditions

Interventions

PROCEDURE

trigger-guided catheter-ablation

trigger-guided ablation of paroxysmal atrial fibrillation

PROCEDURE

trigger+substrate-guided catheter ablation

trigger-+substrate guided ablation of paroxysmal atrial fibrillation

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Claus Schmitt, MD · Deutsches Herzzentrum Muenchen

  • Isabel Deisenhofer, MD · Deutsches Herzzentrum Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2006-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196183 on ClinicalTrials.gov